APA citiranje

Čulig, Z., Hoffmann, J., Erdel, M., Eder, I. E., Hobisch, A., Hittmair, A., . . . Klocker, H. (1999). Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system.

Chicago Style (17th ed.) Citation

Čulig, Zoran, et al. Switch from Antagonist to Agonist of the Androgen Receptor Blocker Bicalutamide Is Associated with Prostate Tumour Progression in a New Model System. 1999.

MLA citiranje

Čulig, Zoran, et al. Switch from Antagonist to Agonist of the Androgen Receptor Blocker Bicalutamide Is Associated with Prostate Tumour Progression in a New Model System. 1999.